Catecholamine-mediated neurotransmission through the activity of amygdaloid dopamine D2 receptors (D2Rs) has been implicated in modulating fear and anxiety (Pezze and Feldon, 2004; de la Mora et al., 2010; Zarrindast and Khakpai, 2015). This evidence concerns the gene DRD2 and Anxiety.